HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Zhang Selected Research

Residual Neoplasm

1/2020Response to immunohistochemical markers' conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis.
12/2014Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
12/2004MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Zhang Research Topics

Disease

62Neoplasms (Cancer)
10/2023 - 01/2000
24Infections
08/2023 - 05/2000
12Neoplasm Metastasis (Metastasis)
03/2023 - 11/2001
12Breast Neoplasms (Breast Cancer)
01/2020 - 01/2000
11Hypoxia (Hypoxemia)
01/2024 - 12/2000
9Carcinoma (Carcinomatosis)
07/2022 - 05/2000
9Pain (Aches)
12/2020 - 05/2010
8Inflammation (Inflammations)
08/2022 - 01/2001
8Hepatocellular Carcinoma (Hepatoma)
04/2022 - 06/2000
7Type 2 Diabetes Mellitus (MODY)
06/2021 - 07/2009
7Schizophrenia (Dementia Praecox)
10/2018 - 07/2003
7Carcinogenesis
01/2018 - 01/2000
6Prostatic Neoplasms (Prostate Cancer)
05/2023 - 06/2000
5Myocardial Infarction
12/2023 - 11/2000
5Lymphatic Metastasis
01/2023 - 10/2000
5COVID-19
05/2021 - 08/2020
5Pneumonia (Pneumonitis)
12/2020 - 07/2000
5Urinary Bladder Neoplasms (Bladder Cancer)
12/2020 - 09/2014
5Ischemia
01/2017 - 01/2000
5Alzheimer Disease (Alzheimer's Disease)
01/2015 - 01/2000
4Leukemia
10/2023 - 12/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 10/2000
4Ovarian Neoplasms (Ovarian Cancer)
07/2022 - 10/2000
4Necrosis
10/2021 - 12/2001
4Body Weight (Weight, Body)
06/2021 - 07/2000
4Fibrosis (Cirrhosis)
01/2017 - 05/2000
4Insulin Resistance
03/2016 - 06/2001
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2024 - 12/2004
3Hemorrhage
12/2023 - 05/2022
3Wounds and Injuries (Trauma)
06/2023 - 08/2000
3Heart Diseases (Heart Disease)
11/2021 - 07/2004
3Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
03/2021 - 10/2018
3Periodontitis
02/2021 - 02/2011
3Edema (Dropsy)
12/2020 - 01/2001
3Lung Neoplasms (Lung Cancer)
11/2020 - 09/2001
3Hypertension (High Blood Pressure)
06/2020 - 10/2001
3Sepsis (Septicemia)
06/2020 - 09/2008
3Squamous Cell Carcinoma of Head and Neck
01/2020 - 05/2014
3Residual Neoplasm
01/2020 - 12/2004
3Acquired Immunodeficiency Syndrome (AIDS)
12/2019 - 12/2007
3Colorectal Neoplasms (Colorectal Cancer)
06/2019 - 09/2002
3Spontaneous Abortion (Miscarriage)
05/2018 - 02/2010
3Atherosclerosis
12/2017 - 01/2001
3Chronic Hepatitis B
11/2017 - 04/2001
3Bacterial Infections (Bacterial Infection)
03/2017 - 04/2000
3Hepatitis B
01/2017 - 12/2001
3Colonic Neoplasms (Colon Cancer)
04/2014 - 12/2013
3Lung Injury
09/2013 - 08/2000
3Dehydration (Water Stress)
07/2009 - 08/2001
2Reperfusion Injury
03/2024 - 09/2000
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2023 - 09/2010

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
07/2023 - 01/2000
13Biomarkers (Surrogate Marker)IBA
12/2023 - 10/2006
12Messenger RNA (mRNA)IBA
10/2021 - 01/2000
10AntigensIBA
07/2017 - 05/2000
9Long Noncoding RNAIBA
04/2022 - 09/2016
7Therapeutic UsesIBA
01/2022 - 01/2010
7Glucose (Dextrose)FDA LinkGeneric
06/2021 - 01/2000
7Phosphotransferases (Kinase)IBA
07/2017 - 05/2000
6VaccinesIBA
09/2020 - 04/2001
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 06/2000
5MicroRNAs (MicroRNA)IBA
03/2024 - 01/2014
5CytokinesIBA
03/2024 - 07/2000
5Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 04/2000
5EnzymesIBA
03/2022 - 08/2001
5LipidsIBA
01/2020 - 06/2001
5InterferonsIBA
06/2018 - 07/2000
4Indicators and Reagents (Reagents)IBA
09/2019 - 01/2014
4Monoclonal AntibodiesIBA
10/2016 - 09/2000
4Mitochondrial DNA (mtDNA)IBA
07/2004 - 06/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2024 - 03/2015
3NF-kappa B (NF-kB)IBA
03/2024 - 01/2001
3Carcinoembryonic AntigenIBA
02/2024 - 07/2017
3Transcription Factors (Transcription Factor)IBA
10/2021 - 06/2014
3Glutathione Transferase (Glutathione S-Transferase)IBA
03/2021 - 10/2018
3ThiramFDA Link
03/2021 - 10/2018
3CateninsIBA
12/2020 - 01/2018
3RNA (Ribonucleic Acid)IBA
01/2020 - 05/2001
3Antipsychotic Agents (Antipsychotics)IBA
10/2018 - 01/2016
3Immunoglobulins (Immunoglobulin)IBA
04/2018 - 04/2008
3Glycogen Synthase (Synthase I)IBA
01/2018 - 07/2013
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 09/2014
3Lamivudine (Epivir)FDA Link
01/2017 - 05/2000
3AlbuminsIBA
11/2016 - 07/2012
3Interleukin-12 (IL 12)IBA
11/2015 - 07/2000
3Methotrexate (Mexate)FDA LinkGeneric
04/2015 - 01/2008
3IGF Type 1 Receptor (IGF 1 Receptor)IBA
11/2003 - 06/2000
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2024 - 02/2011
2Oxygen (Dioxygen)IBA
01/2024 - 06/2014
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2023 - 02/2013
2Complement System Proteins (Complement)IBA
08/2023 - 07/2012

Therapy/Procedure

37Therapeutics
03/2024 - 01/2000
9Radiotherapy
01/2023 - 06/2000
8Drug Therapy (Chemotherapy)
03/2024 - 10/2000
6Aftercare (After-Treatment)
01/2022 - 11/2013
4Length of Stay
05/2021 - 12/2019
3Neoadjuvant Therapy
09/2023 - 10/2018
3Operative Time
05/2021 - 12/2019
3Ligation
12/2020 - 11/2000
3Operative Surgical Procedures
06/2020 - 01/2005